智通财经APP获悉，葛兰素史克(GSK.US)周三公布第一季度业绩。数据显示，该公司Q1营收为73.6亿英镑(合91.8亿美元)，按固定汇率(CER)计算同比增长10%，高于市场预期的70.7亿英镑;每股收益为43.1便士，也高于市场预期的37.3便士。

葛兰素史克上调了全年利润指引，并表示，由于市场对其呼吸道病毒和带状疱疹疫苗的需求强劲，今年上半年的销售额将高于下半年。

该制药商目前预计，2024年调整后每股收益的增长率为8%至10%，高于此前预测的6%至9%。该公司还预计，2024年营收增幅将达到5%至7%的预测区间的上限。

葛兰素史克首席执行官Emma Walmsley的战略重点是加强对疫苗和传染病药物的关注，并将其对艾滋病毒的关注转向长效治疗和预防疗法。随着该公司准备从2025年开始推出12款新产品创业板开户交易，这一战略得到了回报。

","del":0,"gnid":"996f83f2392e7728a","img_data":[{"flag":2,"img":[{"desc":"","height":"500","title":"","url":"/uploads/allimg/240729/1120015645-0.jpg","width":"876"}]}],"original":0,"pat":"art_src_3,fts0,sts0","powerby":"pika","pub_time":1714545660000,"pure":"","rawurl":"http://zm.news.so.com/b8d1104e5c6c90d1e4006ca9a88ad662","redirect":0,"rptid":"81e9d7a10cfbd53d","rss_ext":[],"s":"t","src":"智通财经","tag":[{"clk":"keconomy_1:疫苗","k":"疫苗","u":""}],"title":"葛兰素史克(GSK.US)Q1业绩超预期 上调全年利润指引","type":"zmt","wapurl":"http://zm.news.so.com/b8d1104e5c6c90d1e4006ca9a88ad662","ytag":"财经:金融证券:股票","zmt":{"brand":{},"cert":"智通财经官方账号","desc":"每天推送最具价值的港股、美股、A股投资资讯","fans_num":9900,"id":"3222764983","is_brand":"0","name":"智通财经","new_verify":"5","pic":"https://p0.img.360kuai.com/t016eb2528e9a2445c6.jpg","real":1,"textimg":"https://p9.img.360kuai.com/bl/0_3/t017c4d51e87f46986f.png","verify":"0"},"zmt_status":0}","errmsg":"","errno":0}